Arkolith/Insider Trading/ADCT/Form 4

Carmona Jose

Chief Financial OfficerADC Therapeutics SA (ADCT) · full profile →Form 4 · filed Feb 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 13, 2026Grant(A)272K$3.99$1.1M760K
Feb 13, 2026Tax withholding(F)26K$3.99$103K734K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-009278) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML